Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Health Tech
Biotech
Chai infuses AI drug discovery efforts with $130M series B
The round brings Chai’s total valuation to $1.3 billion and comes just months after a $70M series A and the reveal of an antibody-designing model.
Darren Incorvaia
Dec 15, 2025 11:11am
Philips claims AI cardiac imaging developer SpectraWAVE
Dec 15, 2025 10:35am
HeartBeam swells on turning FDA rejection into ECG clearance
Dec 11, 2025 11:50am
Formation Bio makes $605M play for Lynk's TYK2 inhibitor
Dec 10, 2025 10:27am
FDA qualifies 1st AI drug development tool in MASH
Dec 9, 2025 12:12pm
Novartis pens $1.7B atopic disease pact with British biotech
Dec 9, 2025 3:57am
